CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy
CDT Equity Inc. (CDT)
Company Research
Source: GlobeNewswire
NAPLES, Fla. and CAMBRIDGE, United Kingdom, March 23, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today announces that it has completed initial signature mapping of its asset portfolio against Sarborg Limited’s recently curated rare disease database, identifying multiple high-potential opportunities across a range of rare and underserved indications. The analysis, conducted using Sarborg’s proprietary AI Signature Agent platform, evaluated CDT’s portfolio of assets, including its solid-form patent portfolio and its licensed AstraZeneca compounds AZD1656 and AZD5658, against a database of approximately 1,700 rare disease signatures. The Company reports that this work has generated a number of highly differentiated and statistically significant matches across therapeutic areas including immunology, oncology, infectious disease, paediatric and ophthalmology, highlighting potential applications in orphan diseases. The Company believes these finding
Show less
Read more
Impact Snapshot
Event Time:
CDT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CDT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CDT alerts
High impacting CDT Equity Inc. news events
Weekly update
A roundup of the hottest topics
CDT
News
- CDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent FilingsGlobeNewswire
- CDT Equity Inc. Announces Reverse Stock SplitGlobeNewswire
- CDT Equity Stockholders Approve All Proposals at Special Meeting, Positioning the Company for Next Phase of Growth [Yahoo! Finance]Yahoo! Finance
- CDT Equity Stockholders Approve All Proposals at Special Meeting, Positioning the Company for Next Phase of GrowthGlobeNewswire
- CDT Notes Sarborg Expansion into Rare Disease Signature Intelligence [Yahoo! Finance]Yahoo! Finance
CDT
Sec Filings
- 3/25/26 - Form 8-K
- 3/18/26 - Form 8-K
- 3/9/26 - Form 8-K
- CDT's page on the SEC website